Fox News senior medical analyst Dr. Marc Siegel joins 'America's Newsroom' to discuss a potential fentanyl vaccine from ARMR ...

Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

BeOne Medicines is up 75% in 2025 but off recent highs. China’s new private insurance drug list could unlock major growth for ONC in 2026.

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

This company's first product has started to generate revenue.

Fox News senior national correspondent Rich Edson reports on the status of a vaccine that could potentially block fentanyl overdose on 'America's Newsroom.' ...